Artiva Biotherapeutics, Inc. (ARTV) Free cash flow 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$79.3MFY2025 · since FY2023: -$50.7M → -$79.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$79.3M | -42.5% |
| FY2024 | -$55.7M | -9.8% |
| FY2023 | -$50.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ARTV financial trends
ARTV RevenueARTV Net incomeARTV Net marginARTV Gross profitARTV Gross marginARTV Operating incomeARTV Operating marginARTV Operating cash flowARTV Capital expendituresARTV Return on equityARTV Stock buybacksARTV Dividends paidARTV Total assetsARTV Total liabilitiesARTV Shareholders’ equityARTV overview →